Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseLeasesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetWages, Salaries and Other
Ratios

Orchestra BioMed Holdings (OBIO) Depreciation Expense (2024 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Depreciation Expense for 2 consecutive years, with $81000.0 as the latest value for Q3 2025.

  • Quarterly Depreciation Expense rose 6.58% to $81000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $329000.0 through Sep 2025, changed N/A year-over-year, with the annual reading at $308000.0 for FY2024, 7.32% up from the prior year.
  • Depreciation Expense for Q3 2025 was $81000.0 at Orchestra BioMed Holdings, roughly flat from $81000.0 in the prior quarter.
  • The five-year high for Depreciation Expense was $84000.0 in Q4 2024, with the low at $74000.0 in Q1 2024.